FierceBiotech 23 févr. 2026 UPDATED: FDA illuminates new approval pathway for bespoke gene editing therapies
FierceBiotech 14 janv. 2026 JPM26: Illumina working with China on 'a path through' its export troubles, sees academic research environment 'muted' for '26
FierceBiotech 9 janv. 2026 Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
FierceBiotech 9 janv. 2026 Illumina hires former NHGRI Director Eric Green as new chief medical officer